Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ubiquinone | 3 | 2021 | 183 | 0.840 |
Why?
|
Shock, Septic | 8 | 2023 | 769 | 0.780 |
Why?
|
Thiamine | 6 | 2024 | 160 | 0.740 |
Why?
|
Heart Arrest | 9 | 2021 | 1513 | 0.600 |
Why?
|
Emergency Service, Hospital | 13 | 2018 | 7871 | 0.540 |
Why?
|
Lactic Acid | 7 | 2024 | 1139 | 0.460 |
Why?
|
Out-of-Hospital Cardiac Arrest | 4 | 2024 | 339 | 0.450 |
Why?
|
Hospital Mortality | 9 | 2018 | 5293 | 0.370 |
Why?
|
Dizziness | 1 | 2014 | 259 | 0.370 |
Why?
|
Chest Pain | 3 | 2007 | 1091 | 0.350 |
Why?
|
Vertigo | 1 | 2011 | 202 | 0.330 |
Why?
|
Cytochromes c | 3 | 2019 | 173 | 0.320 |
Why?
|
Influenza, Human | 1 | 2018 | 1518 | 0.280 |
Why?
|
Bacteremia | 1 | 2012 | 977 | 0.250 |
Why?
|
Cardiopulmonary Resuscitation | 7 | 2024 | 992 | 0.240 |
Why?
|
Cocaine-Related Disorders | 1 | 2007 | 461 | 0.230 |
Why?
|
Respiratory Insufficiency | 3 | 2017 | 1230 | 0.220 |
Why?
|
Sepsis | 7 | 2017 | 2585 | 0.220 |
Why?
|
Thiamine Deficiency | 2 | 2016 | 48 | 0.210 |
Why?
|
Angina Pectoris | 1 | 2006 | 959 | 0.200 |
Why?
|
Propanolamines | 1 | 2022 | 163 | 0.190 |
Why?
|
Stroke | 4 | 2017 | 9712 | 0.190 |
Why?
|
Myocardial Infarction | 5 | 2007 | 11459 | 0.180 |
Why?
|
Vasoconstrictor Agents | 3 | 2022 | 654 | 0.170 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2020 | 143 | 0.170 |
Why?
|
Neuromuscular Blockade | 1 | 2020 | 147 | 0.160 |
Why?
|
Diagnostic Errors | 1 | 2006 | 1265 | 0.160 |
Why?
|
Multiple Organ Failure | 1 | 2020 | 387 | 0.150 |
Why?
|
Vital Signs | 2 | 2017 | 144 | 0.150 |
Why?
|
Double-Blind Method | 7 | 2024 | 12334 | 0.140 |
Why?
|
Ascorbic Acid | 1 | 2020 | 655 | 0.140 |
Why?
|
Community-Acquired Infections | 2 | 2018 | 469 | 0.140 |
Why?
|
Electrocardiography | 2 | 2007 | 6346 | 0.140 |
Why?
|
Balloon Occlusion | 1 | 2017 | 125 | 0.130 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2017 | 189 | 0.130 |
Why?
|
Middle Aged | 30 | 2024 | 220584 | 0.130 |
Why?
|
Esophageal and Gastric Varices | 1 | 2017 | 207 | 0.120 |
Why?
|
Statistics, Nonparametric | 2 | 2018 | 2849 | 0.120 |
Why?
|
Adrenergic beta-Agonists | 1 | 2016 | 346 | 0.120 |
Why?
|
Acute Disease | 2 | 2018 | 7237 | 0.120 |
Why?
|
Angiopoietin-2 | 1 | 2015 | 172 | 0.120 |
Why?
|
Predictive Value of Tests | 5 | 2018 | 15251 | 0.120 |
Why?
|
Risk Assessment | 3 | 2017 | 23972 | 0.110 |
Why?
|
Shock | 1 | 2016 | 314 | 0.110 |
Why?
|
Intensive Care Units | 4 | 2019 | 3742 | 0.110 |
Why?
|
Male | 32 | 2024 | 360358 | 0.110 |
Why?
|
Aged | 25 | 2024 | 169042 | 0.110 |
Why?
|
Simvastatin | 1 | 2015 | 346 | 0.100 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 1924 | 0.100 |
Why?
|
beta-Alanine | 1 | 2013 | 82 | 0.100 |
Why?
|
Epinephrine | 1 | 2016 | 792 | 0.100 |
Why?
|
Withholding Treatment | 1 | 2016 | 616 | 0.100 |
Why?
|
Female | 32 | 2024 | 392148 | 0.100 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2017 | 619 | 0.100 |
Why?
|
Micronutrients | 1 | 2015 | 381 | 0.100 |
Why?
|
Prospective Studies | 10 | 2019 | 54360 | 0.100 |
Why?
|
Coronary Disease | 1 | 2006 | 5912 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2020 | 1389 | 0.100 |
Why?
|
Pneumonia, Bacterial | 1 | 2014 | 315 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1879 | 0.090 |
Why?
|
Gram-Negative Bacteria | 1 | 2012 | 271 | 0.090 |
Why?
|
Antithrombins | 1 | 2013 | 292 | 0.090 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2012 | 238 | 0.090 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2017 | 1116 | 0.080 |
Why?
|
Humans | 37 | 2024 | 760617 | 0.080 |
Why?
|
Aged, 80 and over | 12 | 2018 | 58894 | 0.080 |
Why?
|
Acidosis, Lactic | 1 | 2010 | 146 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 1 | 2016 | 1551 | 0.080 |
Why?
|
Urinary Tract Infections | 1 | 2014 | 802 | 0.070 |
Why?
|
Hydrocortisone | 1 | 2016 | 1819 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2015 | 1614 | 0.070 |
Why?
|
Benzimidazoles | 1 | 2013 | 858 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 3244 | 0.070 |
Why?
|
Pilot Projects | 3 | 2016 | 8618 | 0.070 |
Why?
|
Coronary Artery Bypass | 1 | 2016 | 2188 | 0.070 |
Why?
|
Risk Factors | 7 | 2017 | 74115 | 0.070 |
Why?
|
Pneumonia | 1 | 2018 | 2143 | 0.070 |
Why?
|
Cause of Death | 1 | 2016 | 3683 | 0.070 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 697 | 0.060 |
Why?
|
Critical Care | 1 | 2018 | 2690 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15828 | 0.060 |
Why?
|
Warfarin | 1 | 2013 | 1477 | 0.060 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2214 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2012 | 1406 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2020 | 80566 | 0.050 |
Why?
|
Vitamin B Complex | 1 | 2024 | 299 | 0.050 |
Why?
|
Hypotension | 2 | 2018 | 878 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2007 | 3410 | 0.050 |
Why?
|
Hemorrhage | 1 | 2013 | 3418 | 0.050 |
Why?
|
Coronary Stenosis | 1 | 2007 | 794 | 0.050 |
Why?
|
Hospitalization | 2 | 2018 | 10704 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12966 | 0.040 |
Why?
|
Adult | 7 | 2020 | 220969 | 0.040 |
Why?
|
Anti-Bacterial Agents | 2 | 2020 | 7402 | 0.040 |
Why?
|
Registries | 4 | 2017 | 8207 | 0.040 |
Why?
|
Logistic Models | 3 | 2016 | 13245 | 0.040 |
Why?
|
Hypernatremia | 1 | 2020 | 78 | 0.040 |
Why?
|
Disease Progression | 1 | 2017 | 13495 | 0.040 |
Why?
|
Tachycardia | 1 | 2022 | 597 | 0.040 |
Why?
|
Norepinephrine | 1 | 2022 | 898 | 0.040 |
Why?
|
Odds Ratio | 1 | 2011 | 9643 | 0.040 |
Why?
|
Organizational Case Studies | 1 | 2019 | 301 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10760 | 0.040 |
Why?
|
Cross Infection | 2 | 2020 | 1422 | 0.040 |
Why?
|
Age Factors | 2 | 2013 | 18381 | 0.040 |
Why?
|
Creatinine | 1 | 2023 | 1896 | 0.040 |
Why?
|
Uremia | 1 | 2018 | 202 | 0.040 |
Why?
|
Cohort Studies | 4 | 2017 | 41457 | 0.040 |
Why?
|
Respiratory Rate | 1 | 2018 | 175 | 0.040 |
Why?
|
Prognosis | 3 | 2019 | 29600 | 0.030 |
Why?
|
Confusion | 1 | 2018 | 278 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10073 | 0.030 |
Why?
|
Hypothermia, Induced | 1 | 2020 | 753 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2007 | 4470 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2016 | 3492 | 0.030 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 352 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2635 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 12447 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15612 | 0.030 |
Why?
|
Drug Repositioning | 1 | 2015 | 233 | 0.030 |
Why?
|
Electric Countershock | 1 | 2016 | 532 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 691 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 1185 | 0.030 |
Why?
|
Survival Rate | 2 | 2017 | 12719 | 0.030 |
Why?
|
Young Adult | 1 | 2018 | 59179 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2020 | 1375 | 0.020 |
Why?
|
Hemodynamics | 1 | 2022 | 4160 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 39913 | 0.020 |
Why?
|
Interleukins | 1 | 2015 | 783 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2871 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6305 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3822 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3575 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2016 | 1866 | 0.020 |
Why?
|
United States | 4 | 2020 | 72272 | 0.020 |
Why?
|
Urban Health Services | 1 | 2010 | 176 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2016 | 1887 | 0.020 |
Why?
|
Comorbidity | 2 | 2017 | 10505 | 0.020 |
Why?
|
Qualitative Research | 1 | 2019 | 3016 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 7389 | 0.020 |
Why?
|
Propensity Score | 1 | 2016 | 1911 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7045 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20556 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6338 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 64568 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2009 | 500 | 0.020 |
Why?
|
Consensus | 1 | 2016 | 3117 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2017 | 2218 | 0.020 |
Why?
|
Survivors | 1 | 2017 | 2372 | 0.020 |
Why?
|
Cholesterol | 1 | 2015 | 2903 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2017 | 2630 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4341 | 0.010 |
Why?
|
Recurrence | 1 | 2017 | 8426 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3797 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8833 | 0.010 |
Why?
|
Inpatients | 1 | 2015 | 2544 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 36402 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12043 | 0.010 |
Why?
|
Hospitals | 1 | 2016 | 3877 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7373 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6418 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10199 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20074 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15689 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21337 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22148 | 0.010 |
Why?
|
Critical Illness | 1 | 2010 | 2709 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22115 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39063 | 0.010 |
Why?
|
Risk | 1 | 2007 | 9604 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2013 | 5031 | 0.010 |
Why?
|
Mice | 1 | 2015 | 81368 | 0.000 |
Why?
|
Animals | 1 | 2015 | 168201 | 0.000 |
Why?
|
Concepts
(174)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_